or Try an Advanced Search...

    Technical Analysis for MOR - MorphoSys AG

    Grade Last Price % Change Price Change
    A 19.34 4.54% 0.84
    MOR closed up 4.54 percent on Thursday, May 16, 2024, on 1.94 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical MOR trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 10.64%
    New 52 Week Closing High Bullish 10.58%
    Narrow Range Bar Range Contraction 10.58%
    Doji - Bearish? Reversal 10.58%
    Wide Bands Range Expansion 10.58%
    Overbought Stochastic Strength 10.58%
    New 52 Week Closing High Bullish 10.96%
    Narrow Range Bar Range Contraction 10.96%
    Wide Bands Range Expansion 10.96%
    Overbought Stochastic Strength 10.96%
    Older End-of-Day Signals for MOR ...

       Recent Intraday Alerts

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MOR Chart by TradingView
    Basic chart:

    Profile

    MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Immunology Infectious Diseases Antibodies Autoimmune Disease Antibody Autoimmunity Inflammatory And Autoimmune Diseases Evotec Morphosys

    Is MOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 MorphoSys gains after Novartis discloses all tender offer conditions were met
    May 10 MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year
    May 1 MorphoSys: Hold Rating Until The Novartis Deal Closes
    Apr 29 MorphoSys reports Q1 results
    Apr 29 MorphoSys AG Reports First Quarter 2024 Financial Results
    Apr 29 New safety risk for MorphoSys drug could complicate Novartis deal - STAT (update)
    Apr 24 MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
    Apr 23 Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
    Apr 12 Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
    Apr 11 Novartis (NVS) to Undertake Job Cuts in Development Department
    See more MOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.5
    52 Week Low 4.185
    Average Volume 488,983
    200-Day Moving Average 11.50
    50-Day Moving Average 18.04
    20-Day Moving Average 18.01
    10-Day Moving Average 18.19
    Average True Range 0.29
    RSI (14) 78.99
    ADX 24.44
    +DI 45.66
    -DI 13.33
    Chandelier Exit (Long, 3 ATRs) 18.63
    Chandelier Exit (Short, 3 ATRs) 17.91
    Upper Bollinger Bands 18.82
    Lower Bollinger Band 17.21
    Percent B (%b) 1.32
    BandWidth 8.98
    MACD Line 0.20
    MACD Signal Line 0.08
    MACD Histogram 0.1187
    Fundamentals Value
    Market Cap 2.91 Billion
    Num Shares 150 Million
    EPS 0.72
    Price-to-Earnings (P/E) Ratio 26.86
    Price-to-Sales 9.95
    Price-to-Book 75.72
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.39
    Resistance 3 (R3) 20.33 19.91 20.22
    Resistance 2 (R2) 19.91 19.65 19.95 20.16
    Resistance 1 (R1) 19.63 19.48 19.77 19.69 20.10
    Pivot Point 19.21 19.21 19.29 19.25 19.21
    Support 1 (S1) 18.93 18.95 19.07 18.99 18.58
    Support 2 (S2) 18.51 18.78 18.55 18.52
    Support 3 (S3) 18.23 18.51 18.47
    Support 4 (S4) 18.29